Lucintel's latest market report analyzed that cell dissociation provides attractive opportunities in pharmaceutical and biotechnology companies, and research and academic institutes. The cell dissociation market is expected to reach $0.7 billion by 2028 with a CAGR of 14.4%. In this market, tissue dissociation is the largest segment by application, whereas pharmaceutical and bioend use industry companies is largest by end use industry.
Download Brochure of this report by clicking on https://www.lucintel.com/cell-dissociation-market.aspx
Based on application, the cell dissociation market is segmented into tissue dissociation and cell detachment. The tissue dissociation segment accounted for the largest share of the market in 2023 and is expected to register the highest CAGR during the forecast period, due to rising government funding for chronic disease research and increase in the R&D expenditure by the pharmaceutical companies for the development of antibodies and personalized treatments.
Browse in-depth TOC on “Cell Dissociation Market”
100 – Figures/Tables
150 – Pages
The Cell Dissociation Market is marked by the presence of several big and small players. Some of the prominent players offering cell dissociation include Merck KGaA, Danaher, Thermo Fisher Scientific, Corning Incorporated, and Becton.
Request Sample Report:
https://www.lucintel.com/cell-dissociation-market.aspx
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.